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Background: Pregnancy-associated glycoproteins (PAGs) were first described as placental antigens present in the
blood serum of the mother soon after implantation. Here, we describe the purification of several pregnancy-
associated glycoproteins from water buffalo placenta (wbPAGs). A specific radioimmunoassay (RIA) was developed
for early pregnancy diagnosis in buffalo species.
Results: Amino-terminal microsequencing of immunoreactive placental proteins allowed the identification of
eleven wbPAGs sequences [Swiss-Prot accession numbers: P86369 to P86379]. Three polyclonal antisera (AS#858,
AS#859 and AS#860) were raised in rabbits against distinct wbPAG fractions. A new RIA (RIA-860) was developed
and used to distinguish between pregnant (n = 33) and non-pregnant (n = 26) water buffalo females.
Conclusions: Our results confirmed the multiplicity of PAG expression in buffalo placenta. In addition, the RIA-860
system was shown to be sensitive, linear, reproducible, accurate and specific in measuring PAG concentrations in
buffalo plasma samples from Day 37 of gestation onwards.
Keywords: Water buffalo, Placenta, Pregnancy-associated glycoprotein, Purification, Radioimmunoassay, Polyclonal
antiserum, Pregnancy diagnosis, N-terminal amino acid sequenceBackground
Domestic buffalo are considered to have low reproductive
efficiency, characterised by late attainment of puberty
and maturity, seasonality of calving, long postpartum
anoestrus, poor expression of oestrus signs, low concep-
tion rate and long calving intervals [1,2]. Furthermore,
there is some evidence of a high rate of embryonic loss,
in particular during the critical phase of embryonic
attachment [3,4]. Thus, an accurate early distinction of
pregnant and non-pregnant animals is essential for im-
provement of reproductive efficiency in buffalo, particu-
larly when breeding techniques such as “out of breeding
season mating” or artificial insemination (AI) are applied.
Moreover, the study of embryonic mortality through the* Correspondence: barbato@unipg.it
†Equal contributors
1Department of Biopathological Veterinary Science, Faculty of Veterinary
Medicine, University of Perugia, Perugia 06126, Italy
Full list of author information is available at the end of the article
© 2013 Barbato et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the ordetection of pregnancy markers could support researchers
aiming to improve oestrus synchronisation and fixed time
AI programs in buffaloes.
Since the early 1980s, a large family of placental proteins
without known biological activity (pregnancy-associated or
pregnancy-specific proteins, namely pregnancy-associated
glycoprotein (PAG) or pregnancy-specific protein B (PSPB))
has been purified from ruminant placenta [5,6]. Some of
them are detected in the peripheral circulation of pregnant
females, and are used as a tool to investigate placental
function in ongoing or endangered pregnancies [7-9].
PAGs are expressed in mono- and binucleate tropho-
blastic cells of the outer epithelial layer in the synepi-
theliochorial cotyledonary placenta [10-13]. Using an
antiserum (AS) raised against bovine PAG (AS#PAG-F4),
Carvalho et al. [14] confirmed that there is a strong
homology between water buffalo and ruminant binucleatel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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glycosylation pattern and characteristics of cell migra-
tion and fusion. Buffalo binucleate cells migrate toward
the maternal epithelium and fuse with a uterine epithe-
lial cell to form a trinucleate cells [14]. Maternal hybrid
trinucleate cells can also further fuse with adjacent cells,
resulting in the formation of a multinuclear syncytium
[15]. However, larger syncytia, with more than three
nuclei, are much less frequent than trinucleate cells in
buffalo placentas [14].
PAG molecules belong to the aspartic proteinase (AP)
superfamily [16] and originated from an ancient PAG-
like precursor by duplication and positive selection ap-
proximately 87 million years ago [17]. It was estimated
that cattle, sheep, and probably other pecoran mammals
possess many, possibly 100 or more, PAG genes [18]. To
date, 74 different complementary DNA (cDNA) of PAG
genes (differing by at least 5% in nucleotide sequence)
have been identified in species with a synepitheliochorial
placenta. In bovine species, 22 PAG genes (boPAG-1 to
boPAG-22) have been cloned and fully sequenced
[11,16,18,19]. The number of identified PAG polypeptide
precursors is lower in ovine (11 ovPAG) [18,20], caprine
(12 caPAG) [12,19], cervid (10 cePAG) [21] and water
buffalo species (wtPAG-1 [22]; wtPAG-2 to wtPAG-19
[Green et al., GenBank direct submission]).
Molecular biology techniques have allowed for huge
progress in understanding the phylogenetic diversity of
PAG molecules. However, these techniques are not ad-
equate to obtain purified and semi-purified PAG prepara-
tions necessary for the development of radioimmunoassay
(RIA) and enzyme-linked immunosorbent assay (ELISA)
protocols. Fortunately, since the 1990s, the selection of
the most convenient chromatography procedures allowed
for the isolation of an important number of native purified
PAG. At present, forty PAG isoforms have been isolated
from cotyledons of the cow [6,23,24], ewe [20,25,26], goat
[27], buffalo [28], bison [29,30], moose and elk [31]. Some
of them were used to immunise rabbits and the antisera
obtained allowed the immunolocalisation of PAG in
placental tissue [10,13,14,32] and the determination of
secretory pattern measured in peripheral maternal
blood (reviewed by Sousa et al. [33]).
In buffalo species, despite efforts made on the purifica-
tion of PAG molecules, the quantity of purified PAG has
not been sufficient to raise new PAG antisera. So far, PAG
concentrations in buffalo species were determined by
heterologous PAG-RIA systems based on antisera raised
against bovine or caprine PAG [34,35]. Interestingly, by
using these systems, concentrations of PAG were remark-
ably distinct from those measured in cattle, increasing
gradually from the 6th week of gestation to parturition
(28th week of pregnancy), and reaching relatively low
peripartum levels [35].Here, we describe the successful isolation and charac-
terisation of new buffalo PAG molecules. These newly
purified proteins were used for the production of three
specific antisera to develop a new PAG-RIA system
(RIA-860). Finally, its ability to discriminate between
pregnant and non-pregnant females was evaluated in
Italian Mediterranean buffalo cows.
Results
Isolation and characterisation of water buffalo PAG
(wbPAG)
Figure 1 schematically shows the protocol used to isolate
wbPAG from fetal cotyledons. Amounts of total protein
(TP) and equivalent immunoreactive PAG contents
(equivPAG; determined by RIA-708) in the different
steps of wbPAG purification are summarised in Table 1.
Highest immunoreactivity was observed at the DEAE 80
mM NaCl (D80) when compared to DEAE 40 mM NaCl
(D40) and DEAE 160 mM NaCl (D160). Sephadex G75
peaks exhibiting the highest PAG/TP ratios (Figure 2)
were loaded onto VVA lectin-affinity chromatography.
The VVA chromatographies of Sephadex G75-D40 Peak
III, G75-D80 Peak II and G75-D160 Peak I and II
resulted in PAG/TP ratios higher than 100% (Table 2).
Table 2 summarises the different purification steps
used to obtain the eleven N-terminal sequenced water
buffalo PAG molecules (wbPAG), as well as their apparent
molecular masses as determined after Coomassie staining
of the PVDF membrane (Figure 3A) and Western blot
(Figure 3B). The apparent molecular masses of immunore-
active PAG isoforms from VVA peaks (revealed by
AS#708) ranged from 55 to 70 kDa. These molecular
masses were systematically slightly lower than those re-
vealed after Coomassie staining of the PVDF membrane
(58 to 76 kDa). Proteins were submitted to Edman degrad-
ation based on their availability (Figure 3A).
The protein sequence data described are available in
the UniProt knowledgebase under the accession num-
bers P86369 to P86379. Isolated wbPAG showed highly
conserved amino acid residues at the beginning of the
N-terminal extremity (RGS-), with Edman sequencing
failing to give any signal on cycle 4 (Table 2). Buffalo se-
quenced N-termini contained the consensus PLR (residues
9 to 11).
When compared, the percentage of amino acid identity
of newly sequenced wbPAG ranged from 80% (between
wbPAG73kDa_B and wbPAG73kDa_I) to 100%. As shown
in Table 2, in their sequenced part, wbPAG65kDa_E,
wbPAG58kDa_F and wbPAG73kDa_I were identical, as well
as wbPAG67kDa_A, wbPAG76kDa_D, wbPAG76kDa_G,
wbPAG63kDa_H and wbPAG60kDa_K.
Screening of the EMBL and Swiss-Prot data banks
revealed 100% identity between four PAG N-termini
characterised here (wbPAG73kDa_B, wbPAG61kDa_C,
Figure 1 Schematic outline of PAG purification from the placentas removed at 8 months of gestation.
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cDNA from buffalo species (Figure 4). Finally, the
micro-sequence comparison also revealed that some
wbPAG forms (wbPAG73kDa_B, wbPAG61kDa_C and
wbPAG63kDa_J) are unique compared to other purified
proteins forms isolated from bovine, ovine, caprine and
bison species (Figure 5).Table 1 Total protein, immunoreactive PAG and ratio of
immunoreactive PAG/total protein in different steps of
purification




Protein extraction 140,897.6 5,719.5 4.1
Acid precipitation 55,598.0 2,919.5 5.2
Ammonium sulfate 40–80% 19,828.5 3,025.5 15.3
DEAE 40 mM NaCl (D40)a 1,132.1 176.3 15.6
Sephadex G75-D40 peak I
(tubes 36–39)
67.2 9.4 14.8
Sephadex G75-D40 peak II
(tubes 40–43)
82.2 24.3 29.6
Sephadex G75-D40 peak III
(tubes 44–47)
39.0 17.0 43.6
DEAE 80 mM NaCl (D80)a 2,481.3 824.2 33.2
Sephadex G75-D80 peak I
(tubes 36–42)
146.4 95.4 65.1
Sephadex G75-D80 peak II
(tubes 43–49)
129.8 74.7 57.5
DEAE 160 mM NaCl (D160)a 3,527.7 174.6 4.9
Sephadex G75-D160 peak I
(tubes 37–38)
74.4 16.2 21.7
Sephadex G75-D160 peak II
(tubes 39)
31.5 7.7 24.4
aEight hundred milligrams from each DEAE were loaded on the Sephadex G75.
TP: total protein.
equivPAG: PAG concentrations measured by heterologous RIA.Development and validation of a new PAG RIA
Figure 6 shows displacement of standard (0.2 to 25 ng/
mL) inhibition curves (B/B0) tested using three different
antisera raised against buffalo PAG (AS#858, AS#859
and AS#860). All tested antisera gave very similar slopes.
Highest dilutions of primary antisera were obtained with
AS#860 (1:840,000). Therefore, this system (RIA-860)
was chosen for measuring concentrations of PAG in
water buffalo cows.
Concerning RIA-860 validation, MDL was 0.1 ng/mL.
Parallelism between standard curve and serial dilutions
from a pregnant buffalo female is demonstrated in
Figure 7. Reproducibility measured as the coefficients of
variation intra- and inter-assay was 6.7% (2.3 ± 0.2 ng/
mL) and 8.0% (3.1 ± 0.2 ng/mL), respectively. Regarding
specificity, the presence of different concentrations (0.19
until 1,000 ng/mL) of placental proteins, sugars and
other plasmatic compounds did not alter the binding of
radio-labelled PAG. Finally, regarding recovery, it ranged
from 101 to 110% when concentrations of 10.0 and 2.0
ng/mL were added to a sample containing low PAG
concentrations.
Concentrations of PAG in plasma samples of pregnant
and non-pregnant buffalo cows
From a total of 59 buffalo females used, 33 became preg-
nant after AI, as detected by both rectal palpation and
RIA-860. As shown in Table 3, in non-pregnant animals,
mean PAG concentrations remained under 0.5 ng/mL at
Days 0, 30 and 37 after AI. Two non-pregnant females
exhibited PAG concentrations of 1.0 ng/mL: one female
at Day 0, and the other at Day 30 after AI. In the preg-
nant group, two females exhibited PAG concentrations
under 1.0 ng/mL at Day 30 after AI. In this group,
concentrations increased significantly from Day 0 to 30
and from Day 30 to 37, when the best threshold for
Figure 2 (See legend on next page).
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Figure 2 Sephadex G-75 chromatographic profiles of 40, 80, and 160 mM NaCl-DEAE fractions from the buffalo placentas. The column
(5 × 100 cm) was previously equilibrated with 5 mM ammonium bicarbonate buffer (pH 7.5). Elution of proteins (O.D. at 280 nm) is indicated by a
black line while immunoreactivity RIA-708) is indicated by a grey line. Stippled areas indicate the most immunoreactive fractions.
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animals was observed.
Discussion
Purified native PAG preparations are required for the
development of specific and/or more sensitive immuno-
assay techniques that are currently used for pregnancy
diagnosis and physiopathological investigations in rumin-
ant species [6,27,33]. Our work describes the isolation and
characterisation of different PAGs from buffalo placentas.
Some proteins were used for production of polyclonal
antisera, allowing the development of new radioimmuno-
assay systems. In parallel, our work confirmed the large
heterogeneity of PAG molecules for both molecular mass
and N-terminal amino acid sequence.
Heterogeneity of the PAG subfamily was evoked as
early as 1982, when Butler et al. [5] estimated molecular
mass of bovine PSPB to range from 47 to 53 kDa. How-
ever, after several years, it was not clear if such diversity
was due to the expression of distinct PSPB/PAG forms
in ruminant placenta, to an extensive post-translational
processing in placental tissue (glycosylation, phosphoryl-
ation or others), or to both phenomena. The identifica-
tion of a high number of N-terminal sequences and
cDNA corresponding to different ruminant PAG and the
demonstration of an extensive glycosylation mechanism
in bovine and ovine placenta [36-38] confirmed that
both factors contribute to the PAG diversity described
here and in previous works [24-30]. For instance,Table 2 Characteristics of different eluted fractions giving the






MMc of major stained bands
Coomassie staining Western
D40-G75 peak III > 100% 69 64
D80-G75 peak I 65.8% 73 68
61 59
D80-G75 peak II > 100% 76 70
65 60
58 55
D160-G75 peak I > 100% 76 70
63 60
D160-G75 peak II > 100% 73 68
63 61
60 57
aDetermined by radioimmunoassay. bObtained by weighing each fraction. cApparen
(AS#497 + AS#708, 0.1:0.1 ml, v/v).different numbers of N-glycosylation sites of asparagines
have been observed in PAG isoforms identified in
placentas of cattle, sheep and goats [6,11,12,32,37]. In
cattle, the dominant boPAG67kDa form has been shown
to present 4 potential glycosylation sites and 10% of oli-
gosaccharides content [6]. Multi-antennary oligosaccha-
rides have been shown to represent 17.83% of the
relative molecular mass of ovPAG [37]. The number of
potential sites of glycosylation of buffalo PAG had not
yet been described in the literature. However, as previ-
ously reported, N-terminal sequences of wbPAG failed
to give any signal on cycle 4, this blank cycle being
followed by the consensus sequence L-T that is a charac-
teristic of the N-glycosylation site.
Our results confirm earlier findings of Klisch et al.
[24], Barbato et al. [28] and Kiewiesz et al. [29,30],
who reported that VVA chromatography can be very
useful to enrich placental glycoproteins produced by
binucleate cells. Interestingly, despite several PAG se-
quences have been obtained in buffalo species, none of
them corresponded to the cDNA sequence of buffalo
PAG-1 (SwissProt access number B6D596). In bovine
species (Bos taurus taurus and Bos taurus indicus),
when using the classical purification protocol, a single
major protein (PAG-1) was identified in placental ex-
tracts [6,23]. On the other side, a large heterogeneity
of PAG molecules could be identified in placental ex-
tracts from small ruminants, European and American


















t molecular masses (MM) were estimated after SDS-PAGE and Western blot
Figure 3 Coomassie blue stained PVDF membrane after SDS-
PAGE (A) and Western blot analysis with AS#708 (B). Lane 1:
VVA peak III from the 40 mM NaCl-DEAE fraction. Lane 2: VVA peak I
from the 80 mM NaCl-DEAE fraction. Lane 3: VVA peak II from the 80
mM NaCl-DEAE fraction. Lane 4: VVA peak I from the 160 mM NaCl-
DEAE fraction. Lane 5: VVA peak II from the 160 mM NaCl-DEAE
fraction. Thirty (A) to 50 μg (B) were loaded in lanes 1–5. Molecular
weight standards (kDa; 7 μg/lane) were loaded on the left and the
right sides of each figure. Final dilution of PAG AS#708 was 1:2,000.
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quences of newly purified buffalo PAGs, the interpretation
was limited by the relatively low number of residues
clearly identified (7 to 20 amino acids long). Three of them
(wbPAG65kDa_E, wbPAG58kDa_F and wbPAG73kDa_I)
were identical to wbPAG62kDa, previously isolated from
mid-pregnancy (5 to 6 months) buffalo placenta [28].
Five other sequences (wbPAG67kDa_A, wbPAG76kDa_D,
wbPAG76kDa_G, wbPAG63kDa_H and wbPAG60kDa_K)
were 100% identical to proteins previously characterised
in buffalo (wbPAG73kDa and wbPAG75kDa) [28], ovine
(ovPAG59, -58a, -61b, 60f, -59g) [25,26] and bison
(AmbPAG74kDa, AmbPAG76kDa, EbPAG71kDa_D) placen-
tas [29,30].Figure 4 Comparison of N-terminal amino acid sequences of newly is
databases. Identities between two sequences are expressed as percent. GOur work describes for the first time the production of
polyclonal antisera raised against PAG molecules isolated
from buffalo placenta. Proteins issued from three different
fractions (DEAE 40 mM NaCl, Sephadex G75-Peak III;
DEAE 80 mM NaCl, Sephadex G75-Peak I and DEAE 80
mM NaCl, Sephadex G75-Peak II) were used to immunise
rabbits resulting in the production of three distinct anti-
bodies: AS#858, AS#859 and AS#860, respectively. These
three obtained antisera gave very similar displacement of
standard inhibition curves. This finding was not surprising
because PAG molecules expressed in the same species can
exhibit high sequence identities [20,25,26,30], and thus
probably share common epitopes [11,33].
The highest dilution of primary antiserum (1:840,000)
was obtained with AS#860. The remarkable parallelism
between serial dilutions of pregnant buffalo samples and
the standard curve indicates that RIA-860 is a good
immunoassay allowing distinguishing subtle quantitative
differences in wbPAG concentrations. RIA-860 also
proved to be very repeatable for measurement of PAG
concentrations (intra- and inter-assay CV lower than
8%). Finally, it was observed that MDL of RIA-860 was
equivalent (0.1 ng/mL) to that previously described for
RIA-497 [39], RIA-706 [39-41] and RIA-Pool [41].
The use of PAG/PSPB RIA systems are considered as
reliable method for early pregnancy diagnosis and
follow-up of trophoblastic function in ruminant species
(reviewed by Sousa et al. [33]). Measurements of PAG/
PSPB concentrations in the peripheral circulation of
pregnant and non-pregnant buffalo cows have been
performed using different RIA methods [35,42]. Re-
cently, Barbato et al. [35] compared RIA-497, RIA-706
and RIA-708 (antisera raised against boPAG67kDa,
caPAG55+59kDa and caPAG55+62kDa, respectively) for
detecting PAG molecules in pregnant buffalo females.
They reported that analogous PAG antigens were better
recognised using RIA-706 from week 6 of gestation on-
wards. By using the same PAG-RIA system, Karen et al.olated water buffalo PAG with sequences deduced from DNA
rey squares represent very low sequence identities.
Figure 5 Comparison of the N-terminal amino acid sequences of the newly isolated water buffalo PAG (wbPAG) with ruminant PAG
exhibiting the highest sequence identity. Peptide and DNA sequence databases were screened, and the identities (id) were determined by
the EBI (European Bioinformatics Institute) using the FASTA3 network service. Grey square represent radical substitutions.
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Figure 6 Displacement of standard inhibition curves obtained
with three different antisera raised against buffalo PAG. A
preparation of highly purified boPAG67kDa was used as standard (0.2
to 25 ng/mL) and tracer (30,000 cpm/100 μL).
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between days 31 and 35.
An additional feature of the present study was the ob-
servation of a rapid increase in PAG concentrations
from Day 30 (2.9 ± 0.4 ng/mL) to Day 37 of pregnancy
(11.6 ± 1.6 ng/mL). Interestingly, a rapid increase in PAG
concentration during pregnancy is characteristic of ovine
[43] and caprine species [44]. However, it differs largely
from those described in bovine species, in which PAG
concentrations increase slowly during the first trimester
of gestation [39,45].
In Egyptian buffalo cows, Karen et al. [34] and El-
Battawy et al. [42] described mean PAG concentrations
ranging from 6.4 to 9.8 ng/mL (15 and 5 pregnant fe-
males, respectively) at around Day 30 of pregnancy. Those
values were higher than mean concentrations (2.9 ng/mL)
measured by RIA-860 at Day 30 in Italian MediterraneanFigure 7 Parallelism between standard curve and serial
dilutions of pregnant buffalo plasma samples. Standard curve for
RIA-860 was calculated by linear scale of B/B0 ratio vs. decadic
logarithm of the standard concentration using radiolabelled
boPAG67kDa. Plasma samples from pregnant buffalo were serially
diluted at 1/1, 1/2, 1/4, 1/8, and 1/16.females (n = 33). Egyptian and Mediterranean buffalo cows
are quite different in several aspects. Mediterranean
females have a much higher milk yield than Egyptian
females (12 vs. 5 kg/day) [46,47]. This observation of
low PAG levels in high producing milk females agrees
with previous findings described by Lopez-Gatius et al.
[48] who reported that there is a strong negative correl-
ation between milk production and PAG concentrations
during the first trimester of pregnancy. Differences in
PAG concentrations could also be partially due to other
factors such as breed, placental mass, age of female or
even farm (genetic selection and nutritional manage-
ment) [49]. Moreover, as previously described in bovine
and ovine species, PAG expression is complex through-
out pregnancy. Some PAG molecules are expressed
early, while others only as pregnancy progresses. Other
PAG are also expressed throughout the whole preg-
nancy period [11].
PAG concentrations were detectable in peripheral
plasma of all Italian Mediterranean pregnant buffalo
cows at Day 37. At Day 30, 31 out of 33 pregnant fe-
males were already positive by RIA-860. In dairy and
beef cows, PAG concentrations can be detected as early
as at Day 21 after AI [39]. However, pregnancy diagnosis
is only recommended from Day 28 to 30 because of
important individual variation on PAG appearance in
peripheral blood [50]. According to different authors,
expression of PAG family members as early as Day 7
after fertilisation suggests their potential role in cellular
growth and differentiation, elongation, apposition, attach-
ment and placentogenesis processes [51-54].
On the other hand, in the present study, PAG concen-
trations were higher than 1.0 ng/mL in one non-pregnant
female at Days 0 and 30. Recently, Karen et al. [34] de-
scribed pregnancy diagnosis in Egyptian buffalo cows by
using RIA-706 (antiserum raised against caPAG55+62kDa).
The authors also reported 3/39 and 2/35 incorrect preg-
nancy diagnoses between days 31–35 and 36–40, re-
spectively. The presence of detectable concentrations in
non-pregnant females can be explained by the existence
of extra-placental sources of PAG, as suggested by Zoli
et al. [50]. Indeed, the presence of antigens immunologic-
ally related to PAG has been demonstrated in testicular
and in ovarian extracts, justifying, also, the adjective “asso-
ciated” and not “specific” given to this family of placental
glycoproteins [55].Conclusion
We have described for the first time the use of antisera
raised against buffalo PAG for RIA development and
pregnancy detection in buffalo cows. Moreover, we
showed that RIA-860 was quantitative, precise, accurate
and sensitive in measuring PAG concentrations.
Table 3 Plasma concentrations of PAG measured by using AS#860 in non-pregnant and pregnant buffalo cows
Day after AI Concentrations of PAG (ng/mL)
Non-pregnant (n = 26) Pregnant (n = 33)
Day 0 Mean PAG (ng/mL) 0.48 ± 0.04 0.41 ± 0.04a
[min–max] [0-1.0] [0-0.8]
Day 30 Mean PAG (ng/mL) 0.46 ± 0.06* 2.86 ± 0.39a,b,*
[min–max] [0-1.0] [0.85-11.37]
Day 37 Mean PAG (ng/mL) 0.27 ± 0.05** 11.60 ± 1.61b,**
[min–max] [0-0.8] [3.12-49.00]
PAG concentrations are expressed as mean ± SEM.
AI: artificial insemination.
Values with similar superscripts in the same column are statistically different (aP < 0.01; bP < 0.05).
Significant differences between PAG concentrations from pregnant and non-pregnant females are indicated by asterisks (*P < 0.05; **P < 0.0001).
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Purification of pregnancy-associated glycoproteins from
buffalo placenta
Throughout the procedure, the presence of immunoreac-
tive proteins was screened by PAG RIA-708 and Western
blot techniques, as previously described [28]. Total protein
(TP) concentrations were determined by the Lowry
method [56] with bovine serum albumin (BSA; ICN Bio-
chemicals Inc., Aurora, OH, USA) as the standard. After
Sephadex G-75 and VVA chromatographies, protein
contents were monitored by measuring the UV absorp-
tion at 280 nm.
Two placentas were collected from pregnant buffalo
cows (Bubalus bubalis) immediately after slaughter,
washed with 0.9% NaCl and frozen at –20°C. The stage
of pregnancy was 8 months (determination based on the
day of artificial insemination). Approximately 4 kg of
fetal cotyledons were thawed, finely minced, mixed and
homogenised (2 h, 4°C) in 10 mM potassium phosphate
buffer containing 100 mM KCl (pH 7.6; ratio buffer to
tissue 4:1, v:v) in the presence of protease inhibitors
(PMSF, EDTA, NaN3). After centrifugation (16,000 × g,
1 h, 4°C), a second extraction followed by homogenisation
(2 h, 4°C) was performed. The pellet obtained after centri-
fugation was thawed and frozen five times, before a third
extraction in phosphate buffer.
Supernatants issued from the three extractions were
pooled, adjusted to pH 4.5 with 0.5 M H3PO4 and
allowed to precipitate at 4°C overnight. After centrifu-
gation, the pH of the supernatant was readjusted to 7.6
with 0.5 M KOH solution. Extracted proteins were
then precipitated by ammonium sulphate ((NH4)2SO4)
at 40% saturation (16 h, 4°C) and centrifuged. Add-
itional ammonium sulfate was added to achieve 80% of
saturation (40–80% (NH4)2SO4 fraction). Following 4 h
precipitation, the solution was centrifuged (16,000 × g)
and the pellet was suspended in 10 mM Tris-HCl
buffer (pH 7.6), extensively dialysed against the same
buffer (48 h) and centrifuged (16,000 × g, 1 h) to eliminate
the insoluble proteins.The 40–80% (NH4)2SO4 precipitate was loaded onto a
chromatographic column (14 × 25 cm, 3,800 mL) of
DEAE-Sephadex A25 (Amersham Biosciences, Uppsala,
Sweden) previously equilibrated on 10 mM Tris-HCl
buffer (pH 7.6). Five steps of increasing ionic-strength
buffer (20, 40, 80, 160 and 320 mM NaCl) were used for
the elution of the column. After chromatography, each
fraction was concentrated to a final volume of 200 mL,
extensively dialysed against 5 mM ammonium bicarbon-
ate buffer (pH 8) and lyophilised. Therefore, isolation
was followed independently for the DEAE 40 mM NaCl
(D40), DEAE 80 mM NaCl (D80) and DEAE 160 mM
NaCl fractions (D160).
Batches of 800 mg of proteins issued from D40, D80
and D160 were subjected to gel filtration on a Sephadex
G75 column (5 × 100 cm; Amersham Biosciences) equili-
brated in 5 mM ammonium bicarbonate buffer. After
each gel filtration, proteins from the tube presenting the
highest immunoreactivity were lyophilised and used to
immunise rabbits (Figure 2). The other tubes corre-
sponding to rich fractions were pooled together and
dialysed against 10 mM HEPES buffer (pH 7.5). After
dialysis, each rich fraction was run through an 8 mL
agarose-bound Vicia villosa lectin (VVA) column (0.7 ×
20 cm; Vector Laboratories, Burlingame, CA, USA). Pro-
teins were eluted with 80 mL HEPES buffer containing
50 mM N-acetyl-galactosamine (GalNAc; Acros Organics,
Morris Plains, NJ, USA). All VVA eluted fractions were
pooled, dialysed against 5 mM ammonium bicarbonate
(pH 8), centrifuged (27,000 × g, 15 min) and lyophilised.
The VVA-eluted proteins were separated by one-
dimensional SDS-PAGE. They were either visualised by
Coomassie Brilliant Blue R250 staining, transferred to
PVDF membranes for NH2-terminal microsequencing or
transferred to nitrocellulose membranes for Western
blot analysis as described elsewhere [25]. Amino acid
(aa) micro-sequencing analyses were performed by
Edman degradation on a pulsed liquid-phase protein
sequencer (Procise 492; Applied Biosystems Inc., Foster
City, CA, USA). The N-terminal sequences obtained in
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database (access numbers P86369 to P86379). The NH2-
terminal aa sequences of isolated PAG were compared
with previously deposited full-length sequences of poly-
peptide PAG precursors identified from cloned cDNAs
(GenBank) and to the micro-sequences of identified
native PAG forms (EMBL-EBI). The comparison be-
tween N-terminal amino acid microsequence and those
deduced from cDNA was performed using Blast pro-
gram from NCBI. Identities were determined by the EBI
(European Bioinformatics Institute) using the Fasta 3
network service [57]. Since it is known that the X in pos-
ition 4 is part of a N-glycosylation site in PAG, it was
substituted by asparagines (N) for database searches [18].
Antisera production and determination of their dilutions
for use in routine RIA
Three mature New Zealand white rabbits (AS#858,
AS#859 and AS#860) were immunised with distinct
purified PAG preparations (Figure 1) by intradermal
route [58]. For the first immunisation, 300 μg of proteins
were dissolved in 1.0 mL phosphate buffer 0.5 M (pH
7.5) and emulsified with Freund complete adjuvant
(Difco Labs, Detroit, MI, USA). Booster doses (300 μg)
were injected at 3–4 week intervals (Freund incomplete
adjuvant). Blood was collected from the marginal ear
vein starting one month after the second injection and
then once a month. Rabbit blood samples were allowed
to clot overnight at room temperature. Thereafter, they
were centrifuged at 1,500 × g for 20 min, and the sera
were stored at –20°C until used. The immunisation
protocol was approved by the Animal Ethics Committee
of the University of Liege (Dossier number 95).
In the presence of an excess of antibody, 44%
(AS#858), 45% (AS#859) and 40% (AS#860) of labelled
bovine 67 kDa PAG (boPAG67kDa) were bound. These
antisera were tested at different dilutions to obtain a
tracer-binding ratio in the zero standard (B0) of approxi-
mately 20% (B0/Tc) and a low non-specific binding
(NSB < 1%). The optimal binding ratios were obtained at
initial dilutions of 1/350,000 (AS#858), 1/640,000 (AS#859)
and 1/840,000 (AS#860). The antiserum giving the highest
dilution titre (AS#860) was used for PAG-RIA development
and measurement in plasma samples from buffalo cows.
PAG radioimmunoassay procedure
The PAG measurements were performed according to
the method described by Zoli et al. [50] with some mod-
ifications. All assays were performed in Tris-HCl buffer
(adjusted to pH 7.6) containing 0.1% BSA (Fraction V;
Sigma-Aldrich Co., St Louis, MO, USA). Measurements
were performed in duplicate in polystyrene tubes and
incubations were performed at room temperature (20 to
22°C). Bovine PAG 67 kDa preparation (boPAG67kDa,accession number Q29432) was used as standard and
tracer for all assays. Pure stock boPAG67kDa (lyophilised
powder) was diluted with assay buffer to give standard
curves ranging from 0.2 to 25 ng/mL (preincubated
system). Iodination (Na-I125, Amersham Biosciences)
was carried out according to the Chloramine T method
[59]. The double antibody precipitation system was com-
posed of a mixture of sheep anti-rabbit immunoglobulin
(0.83% v:v), normal rabbit serum (0.17% v:v), polyethyl-
ene glycol 6000 (20 mg/mL; Fluka Biochemika, Buchs,
Switzerland), cellulose microcrystalline (0.05 mg/mL;
Merck, Darmstad, Germany) and BSA (2 mg/mL) di-
luted in Tris buffer (25 mM Tris, 10 mM MgCl2 and
0.02% w/v NaN3; pH 7.5).
Briefly, standard and plasma samples (0.1 mL) were
diluted in 0.1 mL and 0.2 mL of Tris-BSA buffer, re-
spectively. Virgin buffalo heifer serum (PAG-free serum;
0.1 mL) was added to each tube of the standard curve.
The maximum binding (B0) was determined by replacing
standard preparations by 0.1 mL of assay buffer. The
NSB tubes contained 0.3 mL of buffer and 0.1 mL of
PAG-free serum. After the addition of an appropriate
dilution of antiserum (AS#860 at 1:840,000; 0.1 mL), the
serum samples and the standard tubes were incubated
overnight at room temperature (20 to 22°C). The follow-
ing day, 0.1 mL of I125-PAG (≈ 25,000 cpm) was added
and the tubes were incubated for 4 h at room
temperature. For separation of bound and free fractions,
1 mL of second antibody polyethylene glycol (PEG) solu-
tion was added to all the tubes and a further incubation
(30 min) at room temperature was performed. The tubes
were then washed with 2 mL of assay buffer and
centrifuged at 2,500 × g at 4°C for 30 min. The super-
natant was discarded and the pellet was washed again
and counted in a gammacounter (Packard Cobra II
AutoGamma, Milan, Italy). The same person handled
the entire experimental protocol. The results were
expressed as the ratio (%) between the amounts of tracer
bound to antibody in the presence (B) and in the
absence (B0) of unlabelled PAG.
Validation of PAG radioimmunoassay
The minimum detection limit (MDL) was defined as the
minimum amount of unlabelled PAG that caused a re-
duction in the percentage of tracer bound to the anti-
body greater than twice the standard deviation of 20
determinations of B0.
Parallelism was assessed by serially diluting pregnant
buffalo serum containing relatively high PAG concentra-
tions with PAG-free serum. Parallelism for each RIA sys-
tem was determined by evaluating a sample at its initial
strength (1/1), and at dilutions of 1/2, 1/4, 1/8 and 1/16.
Reproducibility was determined by calculating the
intra- and inter-assay coefficients of variation (CV) as
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same serum was assayed 10 times within the same assay.
The inter-assay reproducibility was assessed by analysing
each serum in four consecutive assays.
Accuracy was determined by adding increasing concen-
trations of purified boPAG67 (1.0, 2.0, 4.0 and 10.0 ng) to
buffalo sera containing known PAG concentrations. These
amounts were chosen to be in the range of PAG concen-
trations generally found during early pregnancy. The per-
centage of recovery was calculated as follows: [observed
value (ng/mL) / expected value (ng/mL)] × 100.
The specificity was verified by testing proteins such as
bovine and sheep haemoglobin (Catalogue number H
2500 and H 2750; Sigma-Aldrich Co.) and serum albumins
from bovine species (Fraction V; Catalogue number
A4503, Sigma-Aldrich Co.), as well as the following
carbohydrate preparations: N-acetyl-D-galactosamine
(Ref. 22585; Acros Inorganics, Geel, Belgium), N-acetyl-
D-glucosamine (Ref. A8625; Sigma-Aldrich Co.) and
N-acetylneuraminic acid (from sheep sub maxillary
gland ≥ 99%; Ref. A 9646; Sigma-Aldrich Co.).
Collection of buffalo plasma samples and experimental
design
The trial was carried out at the experimental farm of the
Animal Breeding Research Center of Monterotondo (Rome,
Italy, 42° N parallel). Fifty-nine Italian Mediterranean
buffalo cows of different ages and parity were used for
determination of PAG concentrations. The animals were
housed in an open paddock, fed ad libitum on total mixed
ration based on maize silage, alfalfa hay, soya bean meal,
maize meal and barley meal (containing 0.90 UFL/Kg of
dry matter (DM) and 15% crude protein on DM) and
milked twice daily.
The buffalo cows were treated with a progesterone-
releasing intravaginal device (PRID®; Sanofi, France),
containing 1.55 g natural progesterone and a gelatine
capsule with 10 mg oestradiol benzoate (which was
included within the device). PRID® was kept in place for
10 days. On the 7th day after PRID® insertion, an i.m.
injection of 1000 IU of PMSG (Ciclogonina®, Fort
Dodge, Italy) and 0.15 mg of cloprostenol (PGF2alpha
analogue) (Dalmazin®, FATRO, Italy) were given. Buffa-
loes were artificially inseminated using frozen-thawed
semen at 72 and 96 h after PRID® removal. Pregnancy sta-
tus was confirmed by rectal palpation 40 days after AI.
Blood was withdrawn at Days 0, 30 and 37 after artifi-
cial insemination (AI). Approximately 10 mL were col-
lected from the jugular vein into EDTA coated tubes.
Plasma was separated by centrifugation at 2,500 × g for
10 min, and stored at –20°C until assayed. Blood sam-
pling was performed in accordance with good veterinary
practices and approved by the Animal Ethics Committee
of the University of Perugia.Statistical analysis was carried out by using Student t-test.
Concentrations of PAG in pregnant and non-pregnant
buffalo females were expressed as the means ± standard
error of mean (SEM). Statistical significance was considered
at the P < 0.05 level.
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